Background:
The information obtained from the national and international agencies provides a rationale to begin research efforts on the development of an effective vaccine against swine septic pasteurellosis (SSP). At present, there is no vaccine available in India for swine septic pasteurellosis. The development of an effective vaccine of virulent strain and serotypes of P. multocida associated with HS in pigs will not only beneficial to India but also all the SAARC nations will be greatly benefited.:
Technology Details:
Development of P. multocida “Soron” B:2 as a vaccine candidate for the manufacturing of swine (pig) septic pasteurellosis vaccine. Annual vaccination of pigs with oil adjuvant or any other suitable adjuvant swine (pig) septic pasteurellosis vaccine will prevent pasteurellosis in pigs which will reduce economic losses.